148 related articles for article (PubMed ID: 35077918)
1. Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
Radakovic N; Nikolić A; Jovanović NT; Stojković P; Stankovic N; Šolaja B; Opsenica I; Pavic A
Eur J Med Chem; 2022 Feb; 230():114137. PubMed ID: 35077918
[TBL] [Abstract][Full Text] [Related]
2. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
3. Targeting Candida albicans filamentation for antifungal drug development.
Vila T; Romo JA; Pierce CG; McHardy SF; Saville SP; Lopez-Ribot JL
Virulence; 2017 Feb; 8(2):150-158. PubMed ID: 27268130
[TBL] [Abstract][Full Text] [Related]
4. Silver(I) complexes with 4,7-phenanthroline efficient in rescuing the zebrafish embryos of lethal Candida albicans infection.
Pavic A; Savić ND; Glišić BĐ; Crochet A; Vojnovic S; Kurutos A; Stanković DM; Fromm KM; Nikodinovic-Runic J; Djuran MI
J Inorg Biochem; 2019 Jun; 195():149-163. PubMed ID: 30952084
[TBL] [Abstract][Full Text] [Related]
5. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.
Pierce CG; Lopez-Ribot JL
Expert Opin Drug Discov; 2013 Sep; 8(9):1117-26. PubMed ID: 23738751
[TBL] [Abstract][Full Text] [Related]
6. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.
Cui J; Ren B; Tong Y; Dai H; Zhang L
Virulence; 2015; 6(4):362-71. PubMed ID: 26048362
[TBL] [Abstract][Full Text] [Related]
7. Candida albicans Infection Model in Zebrafish (Danio rerio) for Screening Anticandidal Drugs.
Kulatunga DCM; Dananjaya SHS; Nikapitiya C; Kim CH; Lee J; De Zoysa M
Mycopathologia; 2019 Oct; 184(5):559-572. PubMed ID: 31473909
[TBL] [Abstract][Full Text] [Related]
8.
Romo JA; Pierce CG; Esqueda M; Hung CY; Saville SP; Lopez-Ribot JL
Front Cell Infect Microbiol; 2018; 8():227. PubMed ID: 30042929
[TBL] [Abstract][Full Text] [Related]
9. The novel antifungal agent AB-22 displays in vitro activity against hyphal growth and biofilm formation in Candida albicans and potency for treating systemic candidiasis.
Lee KT; Lee DG; Choi JW; Park JH; Park KD; Lee JS; Bahn YS
J Microbiol; 2022 Apr; 60(4):438-443. PubMed ID: 35286605
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of filamentation can be used to treat disseminated candidiasis.
Saville SP; Lazzell AL; Bryant AP; Fretzen A; Monreal A; Solberg EO; Monteagudo C; Lopez-Ribot JL; Milne GT
Antimicrob Agents Chemother; 2006 Oct; 50(10):3312-6. PubMed ID: 17005810
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of antifungal resistance and developments in alternative strategies to combat Candida albicans infection.
Sharma K; Parmanu PK; Sharma M
Arch Microbiol; 2024 Feb; 206(3):95. PubMed ID: 38349529
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory potential of myristic acid and palmitic acid synergism against systemic candidiasis in Danio rerio (Zebrafish).
Prasath KG; Alexpandi R; Parasuraman R; Pavithra M; Ravi AV; Pandian SK
Biomed Pharmacother; 2021 Jan; 133():111043. PubMed ID: 33378951
[TBL] [Abstract][Full Text] [Related]
13. Global Transcriptomic Analysis of the Candida albicans Response to Treatment with a Novel Inhibitor of Filamentation.
Romo JA; Zhang H; Cai H; Kadosh D; Koehler JR; Saville SP; Wang Y; Lopez-Ribot JL
mSphere; 2019 Sep; 4(5):. PubMed ID: 31511371
[TBL] [Abstract][Full Text] [Related]
14. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of a maleimide compound on the virulence factors of
Li Y; Chen C; Cong L; Mao S; Shan M; Han Z; Mao J; Xie Z; Zhu Z
Virulence; 2023 Dec; 14(1):2230009. PubMed ID: 37367101
[TBL] [Abstract][Full Text] [Related]
16. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
Zhang M; Yan H; Lu M; Wang D; Sun S
Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727
[TBL] [Abstract][Full Text] [Related]
18. Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections.
Nile C; Falleni M; Cirasola D; Alghamdi A; Anderson OF; Delaney C; Ramage G; Ottaviano E; Tosi D; Bulfamante G; Morace G; Borghi E
mSphere; 2019 Jan; 4(1):. PubMed ID: 30674648
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of tetrazole derivatives bearing pyrrolidine scaffold and evaluation of their antifungal activity against Candida albicans.
Łukowska-Chojnacka E; Kowalkowska A; Gizińska M; Koronkiewicz M; Staniszewska M
Eur J Med Chem; 2019 Feb; 164():106-120. PubMed ID: 30594027
[TBL] [Abstract][Full Text] [Related]
20. Biofilm of Candida albicans: formation, regulation and resistance.
Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
